Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections

2024-1-1

Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older Individuals

2024-1-1

The Pivotal Role of Molnupiravir in Protecting High-Risk Populations in the Endemic Era of COVID-19: Insight from Real-World Evidence

2024-1-1

Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients: Guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation

2024-1-1

Response to Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy

2024-1-1

Opportunistic Infections in HIV-Infected Children on Treatment in Southern Morocco: A 12-Years Retrospective Follow-Up Study

2024-1-1

Response to “Adult Immunization Policy in Korea”

2024-1-1

Reply: Response to Usefulness of the Rapid Antigen Test in Detecting SARS-CoV-2 for Infection Control in Hospitals

2024-1-1

Antimicrobial Resistance of <i>Streptococcus pneumoniae</i> Clinical Serotypes between 2017 and 2022 in Crete, Greece

2024-1-1

Identification and Antimicrobial Susceptibilities for Patients with Non-tuberculous Mycobacteria Infection in Jeju Island: Single-Center Retrospective Study

2024-1-1

Carbapenem-resistant <i>Acinetobacter baumannii</i> Outbreak in a COVID-19 Isolation Ward and Successful Outbreak Control with Infection Control Measures

2024-1-1

Effectiveness and Tolerability of Dual Therapy with Dolutegravir Plus Darunavir/c in Treatment-Experienced Patients with HIV: A 144-Week Follow-Up

2024-1-1

The Essentiality of Support Groups in Response to the HIV Epidemic in the Philippines

2024-1-1

A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns

2024-1-1

Response to Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study

2024-1-1

Reply to: SARS-CoV-2 Transmission Rate Depends on Infectivity of the Virus Strain, Closeness of Contact, and the Immune Competence of the Infected Person

2024-1-1

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID

2024-1-1

Epidemiology and Disease Burden of Respiratory Syncytial Virus Infection in Adults

2024-1-1

Clinical Characteristics and Severity of Respiratory Syncytial Virus infection in Korean Children during the Post-COVID-19 Pandemic Period

2024-1-1

Usefulness of the Rapid Antigen Test in Detecting SARS-CoV-2 for Infection Control in Hospitals

2024-1-1

Response to Usefulness of the Rapid Antigen Test in Detecting SARS-CoV-2 for Infection Control in Hospitals

2024-1-1

Epidemiological and Clinical Characteristics of Women Living with HIV in Korea

2024-1-1

The Outcome of SARS-CoV-2 Infection in Patients with Lymphoma and the Risk Factors for the Development of Pneumonia

2024-1-1

Response to “A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1”

2024-1-1

Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition

2024-1-1

Determination of Risk Factors for Infectious Diarrhea in Patients with Hematological Malignancy

2024-1-1

Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study

2024-1-1

Impact of Implementing an Antimicrobial Stewardship Program for Optimizing Antibiotic Treatment in Gram-negative Bacilli Bacteremia

2024-1-1

Comparative Effects of Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines in The Prevention of Genotype-Specific Infection: A Systematic Review and Network Meta-Analysis

2024-1-1

Optimizing Treatment for Carbapenem-Resistant <i>Acinetobacter baumannii</i> Complex Infections: A Review of Current Evidence

2024-1-1

High Serum miR-361-3p Predicts Early Postdischarge Infections after Autologous Stem Cell Transplantation

2024-1-1

Possible Bioterrorism by North Korea and South Korea’s Preparedness

2024-1-1

Antiretroviral Therapy during Long-term Surgical Care: ‘Exploring Difficult Cases in HIV Clinics’ of the Korean Society for AIDS Conference in 2023

2024-1-1

Nationwide Analysis of Antimicrobial Prescription in Korean Hospitals between 2018 and 2021: The 2023 KONAS Report

2024-1-1

Reply: Response to Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy

2024-1-1

No Significant Differences in Presepsin Levels According to the Causative Microorganism of Bloodstream Infection

2024-1-1

Response to Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea

2024-1-1

Occult Amebiasis among Pediatric with Enterocolitis in National Referral Hospital in Indonesia

2024-1-1

Clinical and Microbiological Characteristics of ST72 Methicillin-Susceptible <i>Staphylococcus aureus</i>: Comparison with ST72 Methicillin-Resistant <i>S. aureus</i>

2024-1-1

Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events

2024-1-1

Six-Year Study on Cutaneous Leishmaniasis in Al-Muthanna, Iraq: Molecular Identification Using ITS1 Gene Sequencing

2024-1-1

Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy

2024-1-1

Tick-Borne Rickettsiosis and Tsutsugamushi Disease Recorded in 313

2024-1-1

Addressing <i>Campylobacter</i> AMR Transmission in India: Urgent Policy Call

2024-1-1

Piperacillin-Tazobactam Versus Cefotaxime as Empiric Treatment for Febrile Urinary Tract Infection in Hospitalized Children

2024-1-1

Response to Six-Year Study on Cutaneous Leishmaniasis in Al-Muthanna, Iraq: Molecular Identification Using ITS1 Gene Sequencing

2024-1-1

Reply: Response to Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea

2024-1-1

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Seoul, Korea

2024-1-1

Benchmarking Antimicrobial Drug Use: Opportunities and Challenges

2024-1-1

Abstracts of the 14th International Symposium on Antimicrobial Agents and Resistance &amp; 2024 Annual Conference of the Korean Society for Antimicrobial Therapy (ISAAR 2024 &amp; KSAT)

2024-1-1